Drug Development
Drug development for cancer involves identifying, testing, and bringing new cancer therapies to the market. The process begins by pinpointing potential therapeutic targets through genetic and biological research on cancer. Preclinical studies then test the new compound’s safety and effectiveness in lab models before moving into clinical trials, where the treatment's safety, efficacy, and optimal dosage are evaluated in humans.
- Track 11-1 Preclinical Testing
- Track 11-2 Phase I, II, III Trials
- Track 11-3 Regulatory Approval
- Track 11-4 Post-Marketing Surveillance
- Track 11-5 Drug Repurposing